当前位置: X-MOL 学术CA: Cancer J. Clin. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Most patients with cancer are not undergoing germline genetic testing
CA: A Cancer Journal for Clinicians ( IF 254.7 ) Pub Date : 2024-01-19 , DOI: 10.3322/caac.21827
Mike Fillon

“The message is that clinicians should redouble their efforts to identify and test those who are at risk for carrying a genetic alteration that increases the risk of cancer.”Mark E. Robson, MD

Science editor Amy H from Santa Clarita, California, was aware of her immediate family’s heavy cancer history so it came as no surprise to her when she was diagnosed with cancer—a stage 1 tumor in the transverse colon. However, nagging questions remained: Did lifestyle, environment, or other factors play a role in her diagnosis, or could her cancer possibly have been tied to a genetic history?

A new study has found that her uncertainty and anxiety are not uncommon: Most patients with cancer do not undergo germline testing to learn if their cancer may have been associated with an inherited gene mutation. The study appears in the Journal of the American Medical Association (doi:10.1001/jama.2023.9526).



中文翻译:

大多数癌症患者没有接受种系基因检测

“我们传达的信息是,临床医生应该加倍努力,识别和检测那些有可能携带增加癌症风险的基因改变的人。”Mark E. Robson 医学博士

来自加利福尼亚州圣克拉丽塔的科学编辑 Amy H 知道她的直系亲属有严重的癌症病史,因此当她被诊断出患有癌症(横结肠的一期肿瘤)时,她并不感到惊讶。然而,挥之不去的问题仍然存在:生活方式、环境或其他因素是否在她的诊断中发挥了作用,或者她的癌症是否可能与遗传史有关?

一项新的研究发现,她的不确定性和焦虑并不少见:大多数癌症患者都没有接受种系测试来了解他们的癌症是否可能与遗传基因突变有关。该研究发表在《美国医学会杂志》上(doi:10.1001/jama.2023.9526)。

更新日期:2024-01-20
down
wechat
bug